ESC 365 - A dangerous mix: life-threatening arrhythmias during concurrent Flecainide and RAF/MEK inhibitors intake.

HFA Premium Access

A dangerous mix: life-threatening arrhythmias during concurrent Flecainide and RAF/MEK inhibitors intake.

Session: Cardio-oncology 2

Topic: Cardio-Oncology

Speaker: Doctor G. Nangeroni (Orbassano, IT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Giulia Nangeroni

San Luigi Gonzaga University Hospital, Orbassano (Italy)

2 presentations

0 follower

3 more presentations in this session

Genuine biatrial myxoma- the rarest form of myxoma

Speaker: Doctor J. Vidovic (Novi Sad, RS)

Anthracycline-related cardiotoxicity in early puerperium: risk stratification, screening tools and therapeutic options

Speaker: Doctor M. Guillen Marzo (Tarragona, ES)

The challenging approach of a young patient with primary intimal sarcoma of the heart

Speaker: Doctor M. Martinho (Almada, PT)

Access the full session

Cardio-oncology 2

Speakers: Doctor G. Nangeroni, Doctor J. Vidovic, Doctor M. Guillen Marzo, Doctor M. Martinho

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources